SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-15-000146
Filing Date
2015-03-30
Accepted
2015-03-30 15:37:58
Documents
5
Period of Report
2015-03-30
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rgbp20150330form8k.htm 8-K 26504
2 VAINI AGREEMENT rgbp20150330form8kex10_1.htm EX-10.1 11576
3 VALUE QUEST AGREEMENT rgbp20150330form8kex10_2.htm EX-10.2 11228
4 MINEV LETTER AGREEMENT rgbp20150330form8kex10_3.htm EX-10.3 6158
5 GRONEMEYER LETTER AGREEMENT rgbp20150330form8kex10_4.htm EX-10.4 6387
  Complete submission text file 0001607062-15-000146.txt   63002
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 15734275
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1